Article
Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling.
Oncogene - 9 Sept 1999
Jeffers M F, Vande Woude G F
Abstract excerpt
Mutations in Met have been identified in human cancer, and we have previously shown that these mutations deregulate the enzymatic activity of this tyrosine kinase receptor, thereby unleashing its oncogenic potential. Signal transduction via wild type Met has been shown to require the autophosphorylation of two tyrosine doublets; Y8,9 which functions to enhance enzymatic activity, and Y14,15 which provides docking...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
